Literature DB >> 11400555

Analysis of ubidecarenone (CoQ10) aqueous samples using reversed phase liquid chromatography.

S Nazzal1, A A Zaghloul, I K Reddy, M A Khan.   

Abstract

A novel method was developed for the quantitative determination of ubidecarenone (CoQ10) in aqueous media using non aqueous reversed phase liquid chromatography. Standards were prepared by melting the compound in Cremophor EL followed by dilution with distilled water. Samples were then analyzed by a Reverse Phase HPLC method using a Waters Novapak C18, 3.9 x 150 mm column. The mobile phase used was methanol: n-hexane (9:1) at a flow rate of 1.5 ml/min. Response of the detector to the analyte was linear (r: 0.999) over the range of 2.5-100 micrograms ml-1, with a limit of detection of 0.17 microgram ml-1. Acetone used to solubilize CoQ10 in the surfactant and Cremophor EL did not interfere with sample analysis. This method provided a convenient and alternative approach to the existing methods that require organic solvent extractions prior to analysis. Besides, this method enabled the separation of major photolytic decomposition products of CoQ10.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11400555

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  3 in total

1.  Preparation and characterization of novel coenzyme Q10 nanoparticles engineered from microemulsion precursors.

Authors:  Cheng-Hsuan Hsu; Zhengrong Cui; Russell J Mumper; Michael Jay
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

2.  Response surface methodology for the optimization of ubiquinone self-nanoemulsified drug delivery system.

Authors:  Sami Nazzal; Mansoor A Khan
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

3.  Response surface methodology for optimization and characterization of limonene-based coenzyme Q10 self-nanoemulsified capsule dosage form.

Authors:  A Palamakula; Mohammad T H Nutan; Mansoor A Khan
Journal:  AAPS PharmSciTech       Date:  2004-04-26       Impact factor: 3.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.